Logo Logo
Help
Contact
Switch Language to German
Mahner, S.; Lueck, H.-J.; Grischke, E.-M.; Rau, J.; Gropp-Meier, M.; Schmalfeldt, B.; Meier, W.; Hasenburg, A.; Belau, A.; Vergote, I.; Zorr, A.; Huels, R.; Gerber, B.; Bois, A. du; Marme, F.; Hilpert, F.; Canzler, U.; Kurzeder, C. (2016): Chemotherapy (CT) +/- pertuzumab (P) for platinum-resistant ovarian cancer (PROC): AGO-OVAR 2.20/ENGOT-ov14/PENELOPE double-blind placebo-controlled randomized phase 3 trial. In: Oncology Research and Treatment, Vol. 39: p. 97
Full text not available from 'Open Access LMU'.